Gastroenterology practices face some of the highest claim denial rates in outpatient medicine and in 2026, the pressure is intensifying. Denial rates for GI endoscopy procedures have climbed steadily, driven by increasingly aggressive NCCI bundling edits, documentation specificity requirements that most operative templates don’t meet, and prior authorization expansions that catch practices off guard at the point of billing rather than the point of scheduling.
The CPT codes themselves haven’t changed dramatically but how payers interpret, audit, and deny them has. Documentation that cleared adjudication two years ago is now generating post-payment audit requests. Modifier misuse that once resulted in reduced payment now triggers full claim denials. And the screening-to-diagnostic conversion rules that have always been complex are now the leading source of colonoscopy billing errors across Medicare Advantage and commercial plans.
This guide covers the most frequently billed gastroenterology CPT codes in 2026 – EGD codes, colonoscopy codes, capsule endoscopy, through-stoma procedures, modifiers, ICD-10 crosswalks, documentation requirements, and the payer-specific changes billing teams need to act on now.
Table of contents
2026 GI Billing Trends and Denial Patterns
- CPT 43239 (EGD with biopsy) remains top 10 GI CPT code by volume and most audited, with denials concentrated around insufficient documentation of biopsy purpose. Clear operative notes must specify medical necessity for tissue sampling.
- CPT 45385 (snare polypectomy) is heavily audited and several commercial payers now require photo documentation in the EMR confirming snare use. Practices must ensure operative reports include both technique and supporting images to avoid reimbursement denials.
- Capsule endoscopy (91110, 91113) increased nearly 9% year-over-year with prior authorization requirements expanding simultaneously. Providers must verify payer rules before scheduling, as missing authorization is a leading cause of claim denials.
- NCCI bundling edits for 43266 and 45390 are enforced more aggressively in 2026. Billing these services separately produces automatic denials. Documentation must reflect bundled status, and coders should avoid unbundling unless a distinct procedure is clearly supported.
Documentation specificity, modifier accuracy, and payer-specific rule awareness are what separate clean claims from systematic denials in 2026 GI billing.
Most Common GI CPT Codes used
These aren’t just the usual codes from training manuals, they’re the ones actually being billed every day in GI practices across the U.S. From diagnostic scopes to therapeutic interventions, this list reflects real-world frequency and how coders are adapting to documentation and payer changes.
EGD CPT Codes – Upper GI Procedures and Billing Rules
43235 – EGD, diagnostic without biopsy, is used for basic upper GI scoping such as GERD workups, unexplained nausea or abdominal pain. If a biopsy is taken, this code is incorrect. In that case, CPT 43239 must be used instead.
43239 – EGD with biopsy, single or multiple, remains the highest‑volume upper GI CPT code. Documentation must specify biopsy location, specimen count, and clinical reason. In 2026, vague notes such as “biopsy taken” no longer satisfy medical necessity review and trigger audits.
43251 – EGD with removal of lesion by snare technique is used for polyp or lesion removal during upper endoscopy. Documentation must clearly describe the snare technique used. Simply stating “lesion removed” is insufficient and often leads to payer denials or audit concerns.
43254 – EGD with endoscopic mucosal resection is used for larger or sessile lesions. Documentation must include lesion size, location, resection technique, and margins. This level of detail supports medical necessity and ensures compliance with payer requirements for reimbursement.
43266 – EGD with endoscopic stent placement includes pre‑dilation, post‑dilation, and guidewire passage. These components are bundled and should not be billed separately. Unbundling 43266 with dilation codes remains a leading denial trigger, making accurate documentation and coding essential for clean claims.
CPT 43239 is the most billed and most audited upper GI code. Documentation must explicitly include biopsy location, specimen count, and clinical indication. Vague biopsy notes such as “biopsy taken” are the leading denial driver, making detailed operative documentation essential.
Every GI Denial Has a Root Cause
From colonoscopy modifiers to capsule endoscopy authorization workflows, AnnexMed strengthens GI billing accuracy across the entire revenue cycle.
Request a Free GI Billing AssessmentColonoscopy CPT Codes – Billing, Documentation, and Denial Prevention
45378 – Diagnostic colonoscopy, no biopsy or intervention. Used when no abnormality is found and no tissue is taken. Modifier selection determines patient cost-sharing and payer reimbursement classification.Proper documentation ensures accurate claim adjudication and prevents denials.
45380 – Colonoscopy with biopsy is extremely common and frequently used for inflammatory bowel disease workups, abnormal screening follow‑ups, and chronic diarrhea evaluations. Documentation must specify biopsy location, specimen count, and clinical indication. Missing these details is a leading cause of payer denials and audits.
45385 – Colonoscopy with snare polypectomy is one of the highest‑volume colonoscopy codes. Documentation must include snare technique, lesion size and location, and specimen sent to pathology. Several commercial payers now require photo documentation in the EMR confirming snare use to validate reimbursement.
45390 – Colonoscopy with endoscopic mucosal resection is used for larger or sessile lesions. This code includes dilation, which should not be billed separately. As EMR technology expands in ambulatory settings, this procedure is becoming more common and requires precise documentation for compliance.
45398 – Colonoscopy with band ligation is used in hemorrhoid treatment and vascular lesion control. Documentation must specify the clinical indication and the number of bands placed. Clear operative notes are essential to support medical necessity and ensure payer reimbursement without triggering audit concerns.
45385 is the most audited colonoscopy code and operative documentation must specify snare technique and lesion details, not just “polyp removed.”
Screening vs. Diagnostic Colonoscopy Billing
The screening-to-diagnostic conversion is the leading source of colonoscopy billing errors. Getting it wrong means patient over-billing or practice under-reimbursement.
Screening colonoscopy: Performed on an asymptomatic patient for cancer prevention. No patient cost-sharing under ACA. Billed with a screening diagnosis code.
Diagnostic colonoscopy: Performed because of symptoms, abnormal findings, or positive screening test. Standard cost-sharing applies. Billed with a symptomatic diagnosis code.
Here is a table showing when a screening converts and what to bill
| Scenario | Code | Modifier |
| Screening nothing found | 45378 | Modifier 33 (commercial) / no modifier (Medicare) |
| Screening, polyp found and removed | 45385 | Modifier 33 (commercial) / Modifier PT (Medicare) |
| Positive FIT Test – Colonoscopy ordered | 45380 or 45385 | No modifier 33 which is already diagnostic |
| Symptoms discovered during procedure | 45380 or 45385 | No modifier 33 and converted to diagnostic |
Modifier 33 – Preventive services. Used on commercial payer claims when a screening colonoscopy converts to therapeutic.
Modifier PT – Medicare only. Used when a Medicare colorectal cancer screening colonoscopy results in biopsy or polypectomy.
Critical rule:
Modifier 33 and PT are not interchangeable. Using PT on a commercial claim or 33 on a Medicare claim produces automatic denials.
The screening vs. diagnostic distinction must be determined at scheduling. Coding from the start with the right modifier prevents the most common and costliest colonoscopy denial category.
Through-Stoma Colonoscopy Codes
Essential for patients with colostomies or surgical diversions. Verify body part terminology before selecting these codes.
44388 – Diagnostic colonoscopy through stoma 44389, with biopsy 44394, with snare removal 44402, and with stent placement.
The operative note must document the stoma as the point of entry. Billing a standard colonoscopy code for a through-stoma procedure or vice versa produces denials and audit flags.
Capsule Endoscopy CPT Codes
91110 – Capsule endoscopy from the esophagus through the ileum is used for small bowel evaluation including Crohn’s disease, obscure gastrointestinal bleeding, and suspected small bowel pathology. Documentation must specify indication, capsule passage, and findings to support medical necessity and ensure payer reimbursement.
91113 – Capsule endoscopy of the colon is used when traditional colonoscopy is incomplete or contraindicated. Documentation should include clinical reasons for capsule use, bowel preparation quality, and findings.
Modifiers in GI Billing
| Modifier | Purpose | When to Apply | Denial Risk If Wrong |
| 33 | Preventive Service | Commercial screening colonoscopy converting to therapeutic | If used on Medicare use PT instead |
| PT | Medicare colorectal screening | Medicare screening resulting in polypectomy | If used on commercial use 33 instead |
| 59 | Distinct procedural service | Two procedures separately billable under NCCI rules | Overbundling |
| 53 | Discontinued procedure | Colonoscopy terminated before completion | Billing full code for incomplete procedure |
| 52 | Reduced services | Scope didn’t reach cecum | Billing full code for incomplete examination |
| 51 | Multiple procedures | Secondary procedure when billing multiple endoscopic codes | Payer reduces secondary without modifier |
Modifier 33 and PT are the most misused in GI billing. Using the wrong one on the wrong payer produces automatic denials. Build a payer-specific modifier reference into your charge capture workflow.
ICD-10 Codes That Support GI Procedure Medical Necessity
| CPT Code | Common ICD-10 | Description |
| 43235 | K21.0 | GERD with esophagitis |
| 43239 | K92.1 / K57.30 / B96.81 | GI bleeding / diverticulosis / H. pylori |
| 43239 | K90.0 | Celiac disease and biopsy for diagnosis |
| 43254 | K22.70 | Barrett’s esophagus without dysplasia |
| 45378 | Z12.11 | Screening colonoscopy encounter |
| 45380 | K51.90 / K50.90 | Ulcerative colitis / Crohn’s disease |
| 45385 | K63.5 / D12.6 | Polyp of colon / benign neoplasm |
| 45390 | D12.6 / K63.5 | Large polyp or sessile lesion requiring EMR |
| 91110 | K57.31/K92.1 | Diverticulosis with bleeding / Obscure GI bleed |
| 91113 | Z12.11 | Incomplete colonoscopy with colon capsule follow-up |
ICD-10 must align with the clinical indication in the operative report where a diagnosis-procedure mismatch is an independent denial trigger separate from any coding error.
Documentation Requirements Per GI Procedure
| CPT Code | What the Operative Note Must Include |
| 43239 | Biopsy site (esophagus, stomach, duodenum), number of specimens, clinical reason for biopsy |
| 43251 | Snare technique specified, lesion location and size, specimen disposition |
| 43254 | Lesion size, resection technique (en bloc vs. piecemeal), margins, specimen sent to pathology |
| 43266 | Stricture or lesion documented, stent type and size, pre/post dilation noted, do not separately bill dilation |
| 45385 | Snare technique explicitly stated, polyp size and location, retrieval method, pathology ordered |
| 45390 | Lesion characteristics, EMR technique, margin status, specimen handling |
| 91110 / 91113 | Clinical indication, prior failed or contraindicated traditional endoscopy, reading physician interpretation |
Generic “procedure performed” language no longer satisfies 2026 documentation standards. Operative templates must prompt for technique, location, size, and specimen details on every procedure.
Optimize GI Claims With Coding-Driven Billing Support
Gastroenterology CPT codes in 2026 demand documentation precision, modifier accuracy, and payer-specific compliance knowledge that general billing operations consistently underdeliver. The codes are stable but the rules around them are tightening every billing cycle.
AnnexMed delivers structured workflows designed specifically for gastroenterology practices:
- Certified GI coders trained in high‑volume CPT codes.
- NCCI edit compliance to prevent bundling violations.
- Screening‑to‑diagnostic modifier management for colonoscopy claims.
- Prior authorization tracking for capsule endoscopy and advanced procedures.
- Operative documentation review ensuring biopsy purpose, snare technique, and EMR details are captured.
If your GI denial rate is climbing, capsule endoscopy claims are aging, or colonoscopy modifier workflows have not been reviewed against payer standards, the problem is systematic. AnnexMed is built to fix it, protect revenue, and reduce audit exposure across every GI procedure your practice bills.
Turn GI Billing Precision Into Consistent, Predictable Revenue
AnnexMed combines GI coding precision, NCCI compliance oversight, and documentation-driven billing support to reduce denials and accelerate reimbursement.
Schedule a MeetingFAQs
1. What is the difference between CPT 45378 and CPT 45380?
45378 is billed when a diagnostic colonoscopy finds no abnormality and no tissue is taken. 45380 is billed when one or more biopsies are taken , if a biopsy is performed, 45378 is incorrect regardless of specimen count. Document biopsy site and clinical indication for every 45380 claim.
2. When should modifier 33 be used versus modifier PT for colonoscopy?
Modifier 33 is for commercial payer claims when a screening colonoscopy converts to therapeutic, polyp found and removed. Modifier PT is exclusively for Medicare claims in the same scenario. Using PT on a commercial claim or 33 on a Medicare claim produces an automatic denial and build a payer-specific modifier reference into charge capture.
3. Can CPT 45380 and CPT 45385 be billed on the same claim?
Not for the same site. NCCI edits bundle 45380 and 45385 when performed on the same lesion. If biopsy and snare polypectomy were performed at genuinely separate anatomical sites, Modifier 59 can be appended to 45380 but the operative note must document separate locations for each procedure.
4. What ICD-10 supports CPT 43239 for H. pylori testing?
B96.81 (H. pylori as cause of disease) is the primary supporting code when 43239 is performed for H. pylori biopsy. K29.70 (gastritis, unspecified) supports the encounter if H. pylori testing was part of a broader gastritis workup. The biopsy purpose must be documented in the operative note to align with the submitted diagnosis code.
5. What is the correct billing when a colonoscopy is incomplete?
When a colonoscopy is terminated before reaching the cecum, bill the procedure code with Modifier 52 (reduced services) if examination was completed to the extent possible, or Modifier 53 (discontinued procedure) if terminated for patient safety. Do not bill the full procedure code without a modifier and document the reason for termination and extent of examination completed.



